Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non‐small‐cell lung cancer and EGFR mutation
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Adjuvant Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) for the Treatment of People With Resected Stage I to III Non‐small‐cell Lung Cancer and EGFR Mutation." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431474/1/Opioids_for_the_management_of_breakthrough_pain_in_cancer_patients:_Cochrane_systematic_review. Accessed 19 April 2024.
Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non‐small‐cell lung cancer and EGFR mutation. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431474/1/Opioids_for_the_management_of_breakthrough_pain_in_cancer_patients:_Cochrane_systematic_review. Accessed April 19, 2024.
Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non‐small‐cell lung cancer and EGFR mutation. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431474/1/Opioids_for_the_management_of_breakthrough_pain_in_cancer_patients:_Cochrane_systematic_review
Adjuvant Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs) for the Treatment of People With Resected Stage I to III Non‐small‐cell Lung Cancer and EGFR Mutation [Internet]. In: Cochrane Abstracts. [cited 2024 April 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431474/1/Opioids_for_the_management_of_breakthrough_pain_in_cancer_patients:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non‐small‐cell lung cancer and EGFR mutation
ID - 431474
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431474/1/Opioids_for_the_management_of_breakthrough_pain_in_cancer_patients:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -